000	00000nam##2200000za#4500
001	9.646412
003	CaOODSP
005	20200328030041
007	ta
008	150407|1996||||xxc|||||     f|0| 0 eng|d
020	|a0-662-25269-1
040	|aCaOODSP|beng
043	|an-cn---
086	1 |aH21-135/6-1996E
110	1 |aCanada. |bHealth Canada.
245	10|a714-X: an information package / |cIssued by the Canadian Breast Cancer Research Initiative.
260	|aToronto - Ontario : |bHealth Canada |c1996.
300	|aix, 128p. : |c28 cm.
500	|a"714-X is an unconventional cancer therapy developed by Mr. Gaston Naessens, a French-born scientist and researcher, who has worked out of a privately financed laboratory in Quebec for more than 30 years."--Page 3. "One in a series of six Information Packages that attempt to collect, collate and review the available information concerning the safety and effectiveness of specific unconventional agents.... In each case the Information Package has a particular focus on the safety and effectiveness of the agent as a treatment for cancer as opposed to its potential role in prevention or its other health-related effects."--Preface.
504	|aBibliography.
520	3 |a714-X is an unconventional cancer therapy developed by Mr. Gaston Naessens, a French-born scientist and researcher, who has worked out of a privately financed laboratory in Quebec for more than 30 years.--Page 3 One in a series of six Information Packages that attempt to collect, collate and review the available information concerning the safety and effectiveness of specific unconventional agents.... In each case the Information Package has a particular focus on the safety and effectiveness of the agent as a treatment for cancer as opposed to its potential role in prevention or its other health-related effects.--Preface
563	|aSoftcover
590	|a97-11|b1997-03-14
986	|a110-866